We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparative Study of the Effect of Ezetimibe Versus Extended-Release Niacin on Atherosclerosis

This study has been terminated.
(Independent steering committee has stopped the trial based on results of a prespecified, blinded interim analysis. It was not stopped due to safety concerns.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00397657
First Posted: November 9, 2006
Last Update Posted: June 17, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Abbott
Information provided by:
Walter Reed Army Medical Center